Markus Walles

1.4k total citations
53 papers, 1.0k citations indexed

About

Markus Walles is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Markus Walles has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Pharmacology and 17 papers in Oncology. Recurrent topics in Markus Walles's work include Pharmacogenetics and Drug Metabolism (19 papers), Mass Spectrometry Techniques and Applications (12 papers) and Analytical Chemistry and Chromatography (8 papers). Markus Walles is often cited by papers focused on Pharmacogenetics and Drug Metabolism (19 papers), Mass Spectrometry Techniques and Applications (12 papers) and Analytical Chemistry and Chromatography (8 papers). Markus Walles collaborates with scholars based in Switzerland, United States and Germany. Markus Walles's co-authors include Janusz Pawliszyn, Jürgen Borlak, K. Levsen, Wayne M. Mullett, Thomas Thum, Russell P. Grant, Heather Lord, Gian Camenisch, Bev Incledon and Florin Marcel Musteata and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Journal of Chromatography A.

In The Last Decade

Markus Walles

50 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Walles Switzerland 21 329 317 314 164 164 53 1.0k
Carmen Fernández‐Metzler United States 14 236 0.7× 609 1.9× 557 1.8× 101 0.6× 108 0.7× 27 1.4k
Anne‐Françoise Aubry United States 25 199 0.6× 530 1.7× 814 2.6× 200 1.2× 226 1.4× 70 1.8k
Katja Heinig Switzerland 25 362 1.1× 552 1.7× 513 1.6× 319 1.9× 100 0.6× 57 1.6k
Roland F. Staack Germany 22 170 0.5× 452 1.4× 466 1.5× 79 0.5× 106 0.6× 67 1.5k
David Wang‐Iverson United States 13 110 0.3× 256 0.8× 366 1.2× 117 0.7× 76 0.5× 19 931
John A. Masucci United States 19 69 0.2× 272 0.9× 455 1.4× 141 0.9× 104 0.6× 50 1.0k
Sekhar Surapaneni United States 19 105 0.3× 198 0.6× 524 1.7× 86 0.5× 297 1.8× 52 1.8k
Diya Lv China 19 149 0.5× 98 0.3× 474 1.5× 87 0.5× 57 0.3× 47 905
Patrick Bennett United States 13 131 0.4× 252 0.8× 613 2.0× 62 0.4× 135 0.8× 26 1.1k
Václav Martínek Czechia 21 358 1.1× 57 0.2× 830 2.6× 71 0.4× 267 1.6× 54 1.7k

Countries citing papers authored by Markus Walles

Since Specialization
Citations

This map shows the geographic impact of Markus Walles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Walles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Walles more than expected).

Fields of papers citing papers by Markus Walles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Walles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Walles. The network helps show where Markus Walles may publish in the future.

Co-authorship network of co-authors of Markus Walles

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Walles. A scholar is included among the top collaborators of Markus Walles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Walles. Markus Walles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amirabadi, Hossein Eslami, Joanne M. Donkers, Markus Walles, et al.. (2024). Intestinal Cells-on-Chip for Permeability Studies. Micromachines. 15(12). 1464–1464. 1 indexed citations
2.
Schlotterbeck, Götz, et al.. (2023). Potential of measured relative shifts in collision cross section values for biotransformation studies. Analytical and Bioanalytical Chemistry. 416(2). 559–568. 2 indexed citations
3.
Bolleddula, Jayaprakasam, Kevin Brady, Gerard Bruin, et al.. (2022). Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives. Drug Metabolism and Disposition. 50(6). 837–845. 24 indexed citations
4.
Walles, Markus, Michael J. Berna, Wenying Jian, et al.. (2022). A Cross Company Perspective on the Assessment of Therapeutic Protein Biotransformation. Drug Metabolism and Disposition. 50(6). 846–857. 10 indexed citations
5.
Fahrni, Simon, et al.. (2021). Double Trap Interface: A novel gas interface for high throughput analysis of biomedical samples by AMS. Drug Metabolism and Pharmacokinetics. 39. 100400–100400. 6 indexed citations
6.
Walles, Markus, Bettina Rudolph, Thomas Wolf, et al.. (2016). New Insights in Tissue Distribution, Metabolism, and Excretion of [3H]-Labeled Antibody Maytansinoid Conjugates in Female Tumor-Bearing Nude Rats. Drug Metabolism and Disposition. 44(7). 897–910. 11 indexed citations
7.
Heudi, Olivier, Sarah Cianférani, Samuel Barteau, et al.. (2016). The use of generic surrogate peptides for the quantitative analysis of human immunoglobulin G1 in pre-clinical species with high-resolution mass spectrometry. Analytical and Bioanalytical Chemistry. 408(6). 1687–1699. 19 indexed citations
8.
Walles, Markus, Samuel Barteau, Franck Picard, et al.. (2016). The flexibility of a generic LC–MS/MS method for the quantitative analysis of therapeutic proteins based on human immunoglobulin G and related constructs in animal studies. Journal of Pharmaceutical and Biomedical Analysis. 131. 214–222. 7 indexed citations
9.
Kraynov, Eugenia, Ajith V. Kamath, Markus Walles, et al.. (2015). Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White Paper. Drug Metabolism and Disposition. 44(5). 617–623. 70 indexed citations
10.
Krauser, Joel A., Yi Jin, Markus Walles, et al.. (2014). Phenotypic and metabolic investigation of a CSF-1R kinase receptor inhibitor (BLZ945) and its pharmacologically active metabolite. Xenobiotica. 45(2). 107–123. 29 indexed citations
11.
Walles, Markus, Yi Jin, M. RITZAU, et al.. (2013). Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects. Drug Metabolism and Disposition. 41(9). 1626–1641. 23 indexed citations
12.
Krauser, Joel A., et al.. (2012). A Unique Automation Platform for Measuring Low Level Radioactivity in Metabolite Identification Studies. PLoS ONE. 7(6). e39070–e39070. 2 indexed citations
13.
Walles, Markus, et al.. (2007). Comparison of sub‐2‐μm particle columns for fast metabolite ID. Journal of Separation Science. 30(8). 1191–1199. 22 indexed citations
14.
Borlak, Jürgen, et al.. (2005). METABOLISM OF VERAPAMIL IN CULTURES OF RAT ALVEOLAR EPITHELIAL CELLS AND PHARMACOKINETICS AFTER ADMINISTRATION BY INTRAVENOUS AND INHALATION ROUTES. Drug Metabolism and Disposition. 33(8). 1108–1114. 8 indexed citations
15.
Borlak, Jürgen, Markus Walles, K. Levsen, & Thomas Thum. (2003). VERAPAMIL: METABOLISM IN CULTURES OF PRIMARY HUMAN CORONARY ARTERIAL ENDOTHELIAL CELLS. Drug Metabolism and Disposition. 31(7). 888–891. 27 indexed citations
16.
Borlak, Jürgen, Markus Walles, Manfred Elend, et al.. (2003). Verapamil: identification of novel metabolites in cultures of primary human hepatocytes and human urine by LC-MS n and LC-NMR. Xenobiotica. 33(6). 655–676. 20 indexed citations
17.
Walles, Markus, Wayne M. Mullett, & Janusz Pawliszyn. (2003). Monitoring of drugs and metabolites in whole blood by restricted-access solid-phase microextraction coupled to liquid chromatography–mass spectrometry. Journal of Chromatography A. 1025(1). 85–92. 66 indexed citations
18.
Walles, Markus, Thomas Thum, K. Levsen, & Jürgen Borlak. (2002). Verapamil: new insight into the molecular mechanism of drug oxidation in the human heart. Journal of Chromatography A. 970(1-2). 117–130. 19 indexed citations
19.
Walles, Markus, Jürgen Borlak, & K. Levsen. (2002). Application of restricted access material (RAM) with precolumn-switching and matrix solid-phase dispersion (MSPD) to the study of the metabolism and pharmacokinetics of Verapamil. Analytical and Bioanalytical Chemistry. 374(7-8). 1179–1186. 16 indexed citations
20.
Walles, Markus, Thomas Thum, K. Levsen, & Jürgen Borlak. (2001). Verapamil metabolism in distinct regions of the heart and in cultures of cardiomyocytes of adult rats.. PubMed. 29(5). 761–8. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen Fernández‐Metzler Breakdown of academic impact, for papers by Anne‐Françoise Aubry Breakdown of academic impact, for papers by Katja Heinig Breakdown of academic impact, for papers by Roland F. Staack Breakdown of academic impact, for papers by David Wang‐Iverson Breakdown of academic impact, for papers by John A. Masucci Breakdown of academic impact, for papers by Sekhar Surapaneni Breakdown of academic impact, for papers by Diya Lv Breakdown of academic impact, for papers by Patrick Bennett Breakdown of academic impact, for papers by Václav Martínek
Rankless by CCL
2026